New drug duo slashes bad cholesterol in high-risk patients by nearly 49%
New Atlas - 18-May-2025Combo of ezetimibe and obicetrapib shows major LDL drop in Cleveland Clinic trial
Join the club for FREE to access the whole archive and other member benefits.
Combo of ezetimibe and obicetrapib shows major LDL drop in Cleveland Clinic trial
DNase I improved CAR T cell impact and survival in a melanoma model
Investors are taking interest as the company moves toward human trials
Promising preclinical results suggest a clear path towards drug development
TC BioPharm’s Phase 2B trial shows TCB008 is safe with promising early effects in AML
Click on resource name for more details.
Company discovering and developing innovative therapeutic and diagnostic solutions targeting liver diseases
25-Aug-2025
Event about latest progress in the molecular, cellular and organismal basis of aging organised by Uni of Copenhagen (Copenhagen, Denmark)
No blog posts found!